Analyst Thinks Johnson & Johnson Could Hit a $280 Target
A major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Value investing focuses on finding undervalued assets for higher returns. Learn effective strategies to enhance your investment portfolio.
26,852 articlesA major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
KB Home's Q1 2026 results shed light on the company’s earnings trajectory and the housing market dynamics. This guide...
As POST releases its Q2 2026 numbers, investors crave clarity on growth, margins, and guidance. This article breaks d...
Investors are watching Ambarella’s path to 2027 with a focus on growth drivers, margins, and the long-term AI camera ...
Tilray shifted from cannabis focus to a BrewDog partnership in search of diversification. But early UK sales data rai...
Two big market events could move stocks this month. Learn how a Federal Reserve decision and the latest inflation and...
Next week could push the stock market in new directions. Here are three essential signals plus practical moves to sta...
Rising private valuations for SpaceX are fueling chatter about a Tesla takeover. Market participants say the odds spa...
Meta Platforms is accelerating its real-time ai push, aiming to turn data streams into immediate monetization. With 2...
A global surge in World Cup apparel buying is meeting a curious branding trend. France wearing green statue echoes ho...
Citigroup boosts its SanDisk price target to $2,500, arguing a multi-year datacenter expansion and a tighter NAND cyc...
Marvell Technology has bold dreams about joining the trillion-dollar club. This article lays out a practical timeline...